Abstract
Endovascular stent graft treatment for aortic dissection was started from in 1993 in Japan and then spread all over the world. Although preliminary data using home-made device to close the entry site of aortic dissection was reported before the millennium, company-made devices have promoted the expert consensus of endovascular treatment for acute complicated type B dissection. For patient with uncomplicated type B dissection, endovascular treatment promises a better result for reverse remodeling of the false lumen. Stent graft treatment will be a promising therapeutic modality for aortic dissection.
